Is ARK Next Generation Internet ETF a Good Investment?
The ARK Next Generation Internet ETF looks like a pretty…
Buy
57
QBTS Quote, Financials, Valuation and Earnings
Last price:
$5.77
Seasonality move
:
40.11%
Day range:
$4.65 - $6.79
52-week range:
$0.68 - $11.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
112.12x
P/B ratio:
--
Volume:
178.7M
Avg. volume:
85M
1-year change:
593.18%
Market cap:
$1.4B
Revenue:
$8.8M
EPS (TTM):
-$0.42
Analysts' Opinion
-
Consensus RatingD-Wave Quantum has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $2.96, D-Wave Quantum has an estimated downside of -9.15% from its current price of $6.10.
-
Price Target UpsideAccording to analysts, the highest upside price target is $4.50 representing -100% upside increase from its current price of $6.10.
Fair Value
-
According to the consensus of 3 analysts, D-Wave Quantum has -9.15% downside to fair value with a price target of $2.96 per share.
QBTS vs. S&P 500
-
Over the past 5 trading days, D-Wave Quantum has underperformed the S&P 500 by -27.08% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
D-Wave Quantum does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
D-Wave Quantum revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter D-Wave Quantum reported revenues of $1.9M.
Earnings Growth
-
D-Wave Quantum has grown year-over-year earnings for 0 quarters straight. In the most recent quarter D-Wave Quantum reported earnings per share of -$0.11.
Enterprise value:
1.4B
EV / Invested capital:
--
Price / LTM sales:
112.12x
EV / EBIT:
--
EV / Revenue:
146.78x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-22.57x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$6.1M
Return On Assets:
-127.48%
Net Income Margin (TTM):
-783.28%
Return On Equity:
--
Return On Invested Capital:
-198.42%
Operating Margin:
-1103.53%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $7.2M | $8.2M | $9.4M | $2.6M | $1.9M | |
| Gross Profit | $4.4M | $4M | $6.1M | $1.5M | $1M | |
| Operating Income | -$58.5M | -$85M | -$73.5M | -$18.4M | -$20.6M | |
| EBITDA | -$51.4M | -$80.4M | -$70.3M | -$14.7M | -$21.1M | |
| Diluted EPS | -$0.53 | -$0.69 | -$0.42 | -$0.12 | -$0.11 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $26.3M | $58.2M | $35.1M | |
| Total Assets | -- | -- | $38.5M | $70.2M | $49.6M | |
| Current Liabilities | -- | -- | $14.6M | $43.3M | $25.8M | |
| Total Liabilities | -- | -- | $39.2M | $61.4M | $66.5M | |
| Total Equity | -- | -- | -$710K | $8.8M | -$16.9M | |
| Total Debt | -- | -- | $15.6M | $39.2M | $46.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$41.5M | -$56.8M | -$59.4M | -$16.9M | -$18.1M | |
| Cash From Investing | -$608K | -$358K | -$2.6M | -$97K | -$369K | |
| Cash From Financing | $47.9M | $96.7M | $38.1M | $62.8M | $7M | |
| Free Cash Flow | -$42.1M | -$57.2M | -$61.3M | -$17M | -$18.4M | |
QBTS
Sector
Market Cap
$1.4B
$118.9M
Price % of 52-Week High
53.46%
67.86%
Dividend Yield
0%
0%
Shareholder Yield
2.04%
0.91%
1-Year Price Total Return
593.18%
-5.54%
Beta (5-Year)
--
0.919
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$9.03
200-day SMA
Buy
Level
$1.99
Bollinger Bands (100)
Buy
Level
-0.1 - 5.42
Chaikin Money Flow
Buy
Level
73.3M
20-day SMA
Sell
Level
$7.67
Relative Strength Index (RSI14)
Sell
Level
46.76
ADX Line
Sell
Level
18.95
Williams %R
Neutral
Level
-78.5503
50-day SMA
Buy
Level
$4.33
MACD (12, 26)
Buy
Level
1.33
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
738.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-14.1043)
Sell
CA Score
(Annual)
Level (-14.1888)
Buy
Beneish M-Score
(Annual)
Level (-3.4087)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (12.6057)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. The Company’s mission is to unlock the power of quantum computing today to benefit business and society. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the Company’s LeapTM cloud service.
Stock Forecast FAQ
In the current month, QBTS has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The QBTS average analyst price target in the past 3 months is $2.96.
-
Where Will D-Wave Quantum Stock Be In 1 Year?
According to analysts, the consensus estimate is that D-Wave Quantum share price will drop to $2.96 per share over the next 12 months.
-
What Do Analysts Say About D-Wave Quantum?
Analysts are divided on their view about D-Wave Quantum share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that D-Wave Quantum is a Sell and believe this share price will rise from its current level to $2.25.
-
What Is D-Wave Quantum's Price Target?
The price target for D-Wave Quantum over the next 1-year time period is forecast to be $2.96 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is QBTS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for D-Wave Quantum is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of QBTS?
You can purchase shares of D-Wave Quantum via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase D-Wave Quantum shares.
-
What Is The D-Wave Quantum Share Price Today?
D-Wave Quantum was last trading at $5.77 per share. This represents the most recent stock quote for D-Wave Quantum. Yesterday, D-Wave Quantum closed at $6.10 per share.
-
How To Buy D-Wave Quantum Stock Online?
In order to purchase D-Wave Quantum stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Marvell Stock Up?
Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…
Why Is General Electric Stock Going Up?
General Electric Company, doing business these days as GE Aerospace…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
44
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
1
IONQ alert for Jan 10
IonQ [IONQ] is up 7.07% over the past day.
Sell
47
CEG alert for Jan 10
Constellation Energy [CEG] is up 25.15% over the past day.
Sell
8
CRNX alert for Jan 10
Crinetics Pharmaceuticals [CRNX] is down 16.31% over the past day.
